Ajanta Pharma Ltd. Fundamental & Technical Research, Share Price Today

NSE : AJANTPHARM
NIFTY : Nifty 500
NIFTY SECTOR : Nifty Pharma

About Company

Ajanta Pharma Limited is a specialty pharmaceuticals formulation company with a well-diversified Branded Generics business spread across India, the rest of Asia, and Africa. The company has a strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company is committed to investing in innovative products to fill identified gaps and putting major capital allocation into this business. Ajanta’s business also consists of two more verticals: US Generics and Institutional business in Africa.

Market Cap. ₹29,660 Cr.

52 Week - High/Low ₹3,485/2,052

P/E Ratio 33.63

P/B Ratio 8.69

Enterprise Value ₹29,771 Cr.

ROE % 24.26

RSI Value 31.07

EMA 50 2648.48

EMA 200 2692.71

Net Profit 807 Cr.

Net Profit 3year growth 19.48 Cr.

Net Profit 3 year (back) 676 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 17.0 %

Current Ratio 3.87 %

100 Day SMA 2,762 Rs.

200 Day SMA 2,828 Rs.

21 Day SMA 2,601 Rs.

50 Day SMA 2,624 Rs.

Book Value 273 Rs.

EV/EBITDA Ratio 23

QoQ EPS Growth 7 %

QoQ Operating Profit Growth 11 %

QoQ Sales Growth -2 %

Sales Latest Quarter 1,102 Cr.

YoY Sales Growth 2 %

Market Cap. ₹29,660 Cr.

52 Week - High/Low ₹3,485/2,052

P/E Ratio 33.20

P/B Ratio 8.31

Enterprise Value ₹29,570 Cr.

ROE % 23.49

RSI Value 31.07

EMA 50 2648.48

EMA 200 2692.71

Net Profit 816 Cr.

Net Profit 3year growth 3.23 Cr.

Net Profit 3 year (back) 654 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 22.74 %

Current Ratio 3.04 %

100 Day SMA 2,762 Rs.

200 Day SMA 2,828 Rs.

21 Day SMA 2,601 Rs.

50 Day SMA 2,624 Rs.

Book Value 286 Rs.

EV/EBITDA Ratio 22

QoQ EPS Growth 8 %

QoQ Operating Profit Growth 3 %

QoQ Sales Growth -3 %

Sales Latest Quarter 1,146 Cr.

YoY Sales Growth 4 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages